Idarubicin and atrial fibrillation Patient Reports February 12, 2012

Idarubicin Side Effects Report #5120517-4
Idarubicin side effect was reported by a Health Professional from AUSTRALIA on Sept 19, 2006. Female patient, 59 years of age, weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: agitation, atrial fibrillation , blood potassium increased, blood pressure systolic increased, bradycardia, bradypnoea, cardiac arrest , cardio-respiratory arrest, dyspnoea. Idarubicin dosage: (17 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE, ALLOPURINOL, TROPISETRON, LORAZEPAM, METOPROLOL, SERTRALINE, OMEPRAZOLE. Patient died on 09/15/2006.

Idarubicin Side Effects Report #4927947-1
Idarubicin side effect was reported by a Health Professional from AUSTRALIA on Feb 17, 2006. Female patient, 58 years of age, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: abdominal pain , acidosis, acidosis hyperchloraemic, acute pulmonary oedema, atelectasis, atrial fibrillation , blood pressure decreased, cardio-respiratory arrest, diarrhoea. Idarubicin dosage: UNK (9 MG/M2, 1 IN 1 D); INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE, FILGRASTIM, IRBESARTAN, FLUCONAZOLE, VALACYCLOVIR, TAZOCIN. Patient was hospitalized. Patient died on 01/27/2006.

Idarubicin Side Effects Report #4817558-0
Idarubicin side effect was reported by a Health Professional from AUSTRALIA on Oct 24, 2005. Male patient, 33 years of age, weighting 207.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: anuria, atrial fibrillation , cardiac arrest , cardiac tamponade, haematemesis, hepatomegaly, international normalised ratio increased, liver function test abnormal, melaena. Idarubicin dosage: 19 MG (19 MG, CYCLICAL - DAILY), INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient died on 09/10/2005.

Idarubicin Side Effects Report #5192324-8
Idarubicin side effect was reported by a Consumer or non-health professional from AUSTRALIA on July 05, 2006. Male patient, weighting 231.5 lb, was diagnosed with acute myeloid leukaemia, colony stimulating factor prophylaxis and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, atrial fibrillation , cardiac failure congestive, febrile neutropenia, fluid overload, hypokalaemia, hyponatraemia, multi-organ failure. Idarubicin dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, FILGRASTIM. Patient died on 07/20/2006.